Thomas R. Fleming

机构：University of Washington · ORCID：0000-0002-0420-5068

发表论文 342 篇 · 总被引 43693 次 · h-index 82

代表论文

• Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 84)
• A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events (2025 · Statistics in Medicine · 被引 13)
• Monitoring Overall Survival in Pivotal Trials in Indolent Cancers (2024 · Statistics in Biopharmaceutical Research · 被引 13)
• Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting (2023 · JCO Global Oncology · 被引 13)
• Training the Next Generation of Data Monitoring Committee Members (2024 · JACC Heart Failure · 被引 8)
• Bringing data monitoring committee charters into the sunlight (2023 · Clinical Trials · 被引 8)